What is she best known for?
The fields of study she is best known for:
- Immune system
- Gene
- Antibody
The scientist’s investigation covers issues in Cytotoxic T cell, T cell, Immunology, Cell biology and Interleukin 21.
IL-2 receptor, CD28 and Antigen-presenting cell are subfields of Cytotoxic T cell in which her conducts study.
In her research, In vivo and CD137 is intimately related to Virus, which falls under the overarching field of CD28.
Her Antigen-presenting cell study deals with Natural killer T cell intersecting with CD40.
The study of T cell is intertwined with the study of Molecular biology in a number of ways.
Her ZAP70 research extends to Cell biology, which is thematically connected.
Her most cited work include:
- The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses (394 citations)
- Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. (330 citations)
- T cell co-stimulatory molecules other than CD28 (324 citations)
What are the main themes of her work throughout her whole career to date?
Tania H. Watts mostly deals with Immunology, Cytotoxic T cell, T cell, Cell biology and Immune system.
Her Immunology study frequently draws connections between related disciplines such as Receptor.
IL-2 receptor, Interleukin 21, ZAP70, Antigen-presenting cell and Natural killer T cell are among the areas of Cytotoxic T cell where Tania H. Watts concentrates her study.
Her Antigen-presenting cell study incorporates themes from Antigen presentation and CD40.
Tania H. Watts has researched T cell in several fields, including Molecular biology and CD8, Antigen.
Her biological study spans a wide range of topics, including Tumor necrosis factor alpha, Inflammation and Antibody.
She most often published in these fields:
- Immunology (47.73%)
- Cytotoxic T cell (46.21%)
- T cell (46.21%)
What were the highlights of her more recent work (between 2016-2021)?
- T cell (46.21%)
- Immunology (47.73%)
- Cytotoxic T cell (46.21%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include T cell, Immunology, Cytotoxic T cell, Effector and Memory T cell.
Her work on CD137 as part of general T cell research is frequently linked to P110δ, bridging the gap between disciplines.
She regularly links together related areas like Cancer in her Immunology studies.
As part of her studies on Cytotoxic T cell, Tania H. Watts often connects relevant subjects like Virology.
In her work, CD80 and Inflammation is strongly intertwined with Immune system, which is a subfield of Effector.
Her work in Antigen-presenting cell addresses subjects such as Antigen presentation, which are connected to disciplines such as Molecular biology.
Between 2016 and 2021, her most popular works were:
- Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection. (68 citations)
- Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells. (23 citations)
- TRAF1 Signaling in Human Health and Disease. (22 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
Her primary areas of study are T cell, Cancer research, Inflammation, Acquired immune system and Memory T cell.
Her work deals with themes such as Signal transduction and Immunophenotyping, which intersect with T cell.
Her Inflammation study combines topics from a wide range of disciplines, such as Innate immune system, Immune system and Immunity.
Her Innate immune system research is classified as research in Immunology.
Her Immunology research incorporates themes from Agonist and mTORC1.
Her research integrates issues of TRAF1 and Kinase in her study of Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
